Developed Covaxin for a cause, not to make money: Krishna Ella
The Hindu
Bharat Biotech chairman and managing director Krishna Ella on Wednesday said the company took up development of Covaxin as a cause and not to make money.
“As a company, we took it as a cause, not to make money but to help the country and save people’s lives,” he said in a video message that was shared by the company with a statement on an interim Phase 3 trial results of Covaxin that showed 81% efficacy.
More Related News
Deepthi Priya, PG student of AMC, bags gold medal for best research paper. Sunitha of Department of Microbiology bags the second prize, while Krishna Manasa of Department of Biochemistry gets consolation prize. Andhra Medical College hosted the 2024 Prof. Dr. E. Pedaveera Raju Gold Medal for Best Research Paper in Investigative Medicine for PGs in the departments of Pathology, Biochemistry, Microbiology and Radiology.